As America’s baby boomer population matures, there is an increasing interest in supplements that can delay or oppose the aging process. This antiaging movement has exploded over the past decade. While most supplements are not supported by scientific literature or government controls, a number of products have been the subject of significant scientific inquiry. Hormone replacement therapy, including testosterone and growth hormone, has mixed results, and antioxidative strategies are supported by basic science but lack clinical evidence-based outcomes. While the process of aging has become better understood leading to more rational approaches to combat its effects on health, the clinician is reminded to carefully discern between the science and marketing that is available in this area.
BarronAMPikeCJ. Sex hormones, aging, and Alzheimer’s disease. Front Biosci (Elite Ed). 2012;4:976-997.
2.
BaurJASinclairDA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5:493-506.
3.
BhasinSBagatellCJBremnerWJ. Issues in testosterone replacement in older men. J Clin Endocrinol Metab. 1998;83:3435-3448.
4.
BhasinSWoodhouseLCasaburiR. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab. 2001;281:E1172-E1181.
5.
BhutadaPMundhadaYBansodK. Ameliorative effect of quercetin on memory dysfunction in streptozotocin-induced diabetic rats. Neurobiol Learn Mem. 2010;94:293-302.
6.
BoocockDJFaustGEPatelKR. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev. 2007;16:1246-1252.
7.
Brown-Sequard. The effects produced on man by subcutaneous injections of liquid obtained from the testicles of animals. Lancet. 1889;2:105.
8.
BuhrmannCMobasheriABuschF. Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem. 2011;286:28556-28566.
9.
CarrollPVUmplebyMAlexanderEL. Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment. Clin Endocrinol (Oxf). 1998;49:739-746.
10.
CherrierMMAsthanaSPlymateS. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology. 2001;57:80-88.
11.
ChowdhuryTTSalterDMBaderDLLeeDA. Signal transduction pathways involving p38 MAPK, JNK, NFkappaB and AP-1 influences the response of chondrocytes cultured in agarose constructs to IL-1beta and dynamic compression. Inflamm Res. 2008;57:306-313.
12.
CraryD. As US grays, and anti-aging niche grows: baby boomers spending billions to counter clock. http://azcentral.com. Accessed January 26, 2013.
13.
CsakiCMobasheriAShakibaeiM. Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis. Arthritis Res Ther. 2009;11:R165.
14.
CullenJJWeydertCHinkhouseMM. The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. Cancer Res. 2003;63:1297-1303.
15.
Da RosCTAverbeckMA. Twenty-five milligrams of clomiphene citrate presents positive effect on treatment of male testosterone deficiency: a prospective study. Int Braz J Urol. 2012;38:512-518.
16.
DaltonJTMukherjeeAZhuZKirkovskyLMillerDD. Discovery of nonsteroidal androgens. Biochem Biophys Res Commun. 1998;244:1-4.
17.
DepeintFGeeJMWilliamsonGJohnsonIT. Evidence for consistent patterns between flavonoid structures and cellular activities. Proc Nutr Soc. 2002;61:97-103.
EdwardsJPWestSJPooleyCLMarschkeKBFarmerLJJonesTK. New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g] quinolinone. Bioorg Med Chem Lett. 1998;8:745-750.
20.
FernholmRBramnertMHaggE. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease. J Clin Endocrinol Metab. 2000;85:4104-4112.
21.
FerriniRLBarrett-ConnorE. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol. 1998;147:750-754.
22.
GharibHCookDMSaengerPH. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children: 2003 update. Endocr Pract. 2003;9:64-76.
23.
GoelAKunnumakkaraABAggarwalBB. Curcumin as “curecumin”: from kitchen to clinic. Biochem Pharmacol. 2008;75:787-809.
24.
GrayAFeldmanHAMcKinlayJBLongcopeC. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 1991;73:1016-1025.
25.
GruenewaldDAMatsumotoAM. Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc. 2003;51:101-115.
26.
HaddadRMKennedyCCCaplesSM. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc. 2007;82:29-39.
27.
HarmanSMMetterEJTobinJDPearsonJBlackmanMR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men: Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86:724-731.
28.
HellerCMMyersGB. The male climacteric: its symptamatology, diagnosis, and treatment. JAMA. 1944;126:472.
29.
HenrotinYClutterbuckALAllawayD. Biological actions of curcumin on articular chondrocytes. Osteoarthritis Cartilage. 2010;18:141-149.
30.
HogervorstEBandelowSCombrinckMSmithAD. Low free testosterone is an independent risk factor for Alzheimer’s disease. Exp Gerontol. 2004;39:1633-1639.
31.
HogervorstEWilliamsJBudgeMBarnetsonLCombrinckMSmithAD. Serum total testosterone is lower in men with Alzheimer’s disease. Neuro Endocrinol Lett. 2001;22:163-168.
32.
HollmanPCKatanMB. Bioavailability and health effects of dietary flavonols in man. Arch Toxicol Suppl. 1998;20:237-248.
33.
HollmanPCKatanMB. Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol. 1999;37:937-942.
34.
HollowayLKohlmeierLKentKMarcusR. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women. J Clin Endocrinol Metab. 1997;82:1111-1117.
35.
HowitzKTBittermanKJCohenHY. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425:191-196.
36.
HughesVAFronteraWRRoubenoffREvansWJSinghMA. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr. 2002;76:473-481.
37.
IsidoriAMGiannettaEGrecoEA. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf). 2005;63:280-293.
38.
JanowskyJSChavezBOrwollE. Sex steroids modify working memory. J Cogn Neurosci. 2000;12:407-414.
JockenhovelF. Testosterone therapy: what, when and to whom?Aging Male. 2004;7:319-324.
41.
JohannssonGGrimbyGSunnerhagenKSBengtssonBA. Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults. J Clin Endocrinol Metab. 1997;82:2877-2884.
42.
JordanWPJr.Allergy and topical irritation associated with transdermal testosterone administration: a comparison of scrotal and nonscrotal transdermal systems. Am J Contact Dermat. 1997;8:108-113.
43.
KaruppagounderSSPintoJTXuHChenHLBealMFGibsonGE. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer’s disease. Neurochem Int. 2009;54:111-118.
44.
KatzDJNabulsiOTalRMulhallJP. Outcomes of clomiphene citrate treatment in young hypogonadal men. BJU Int. 2012;110:573-578.
45.
KerinJFLiuJHPhillipouGYenSS. Evidence for a hypothalamic site of action of clomiphene citrate in women. J Clin Endocrinol Metab. 1985;61:265-268.
46.
KerryNLAbbeyM. Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro. Atherosclerosis. 1997;135:93-102.
47.
KnektPJarvinenRSeppanenR. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol. 1997;146:223-230.
48.
KoppulaSKumarHMoreSVLimHWHongSMChoiDK. Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson’s disease. Molecules. 2012;17:11391-11420.
49.
LambertsSWvan den BeldAWvan der LelyAJ. The endocrinology of aging. Science. 1997;278:419-424.
50.
LeibovitzBESiegelBV. Aspects of free radical reactions in biological systems: aging. J Gerontol. 1980;35:45-56.
51.
LiuHBravataDMOlkinI. Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med. 2008;148:747-758.
52.
LiuHBravataDMOlkinI. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med. 2007;146:104-115.
53.
LiuPYPincusSMKeenanDMRoelfsemaFVeldhuisJD. Analysis of bidirectional pattern synchrony of concentration-secretion pairs: implementation in the human testicular and adrenal axes. Am J Physiol Regul Integr Comp Physiol. 2005;288:R440-446.
54.
ManachCMorandCDemigneCTexierORegeratFRemesyC. Bioavailability of rutin and quercetin in rats. FEBS Lett. 1997;409:12-16.
55.
ManlyJJMerchantCAJacobsDM. Endogenous estrogen levels and Alzheimer’s disease among postmenopausal women. Neurology. 2000;54:833-837.
56.
Mathy-HartertMJacquemond-ColletIPriemFSanchezCLambertCHenrotinY. Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflamm Res. 2009;58:899-908.
57.
MehtaAHindmarshPC. The use of somatropin (recombinant growth hormone) in children of short stature. Paediatr Drugs. 2002;4:37-47.
58.
MillerER3rdPastor-BarriusoRDalalDRiemersmaRAAppelLJGuallarE. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37-46.
59.
MoffatSDZondermanABMetterEJBlackmanMRHarmanSMResnickSM. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab. 2002;87:5001-5007.
60.
MorleyJE. Hormones and the aging process. J Am Geriatr Soc. 2003;51:S333-S337.
61.
NarayananRMohlerMLBohlCEMillerDDDaltonJT. Selective androgen receptor modulators in preclinical and clinical development. Nucl Recept Signal. 2008;6:e010.
62.
NguyenTVEismanJAKellyPJSambrookPN. Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol. 1996;144:255-263.
63.
PalsamyPSubramanianS. Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomed Pharmacother. 2008;62:598-605.
64.
PandeyKBRizviSI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev. 2009;2:270-278.
65.
PaolettiAMCongiaSLelloS. Low androgenization index in elderly women and elderly men with Alzheimer’s disease. Neurology. 2004;62:301-303.
66.
PapadakisMAGradyDBlackD. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med. 1996;124:708-716.
67.
PearsonKJBaurJALewisKN. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 2008;8:157-168.
68.
PerlsTTReismanNROlshanskySJ. Provision or distribution of growth hormone for “antiaging”: clinical and legal issues. JAMA. 2005;294:2086-2090.
69.
PiettaPG. Flavonoids as antioxidants. J Nat Prod. 2000;63:1035-1042.
70.
PirkeKMDoerrP. Age related changes in free plasma testosterone, dihydrotestosterone and oestradiol. Acta Endocrinol (Copenh). 1975;80:171-178.
71.
Rodriguez-ArnaoJJabbarAFulcherKBesserGMRossRJ. Effects of growth hormone replacement on physical performance and body composition in GH deficient adults. Clin Endocrinol (Oxf). 1999;51:53-60.
72.
RubensRDhontMVermeulenA. Further studies on Leydig cell function in old age. J Clin Endocrinol Metab. 1974;39:40-45.
73.
RudmanDFellerAGNagrajHS. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990;323:1-6.
74.
SantavirtaSKonttinenYTHeliovaaraMKnektPLuthjePAromaaA. Determinants of osteoporotic thoracic vertebral fracture: screening of 57,000 Finnish women and men. Acta Orthop Scand. 1992;63:198-202.
75.
SatueMArrieroMDMonjoMRamisJM. Quercitrin and Taxifolin stimulate osteoblast differentiation in MC3T3-E1 cells and inhibit osteoclastogenesis in RAW 264.7 cells [published online September 20, 2013]. Biochem Pharmacol.
76.
Selling the Promise of Youth. Business Week. Vol 2006: McGraw-Hill; 2006.
77.
ShabsighAKangYShabsignR. Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism. J Sex Med. 2005;2:716-721.
78.
ShutenkoZHenryYPinardE. Influence of the antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion. Biochem Pharmacol. 1999;57:199-208.
79.
SokolRZPalaciosACampfieldLASaulCSwerdloffRS. Comparison of the kinetics of injectable testosterone in eugonadal and hypogonadal men. Fertil Steril. 1982;37:425-430.
80.
StannerSAHughesJKellyCNButtrissJ. A review of the epidemiological evidence for the “antioxidant hypothesis.” Public Health Nutr. 2004;7:407-422.
81.
TanRSCulbersonJW. An integrative review on current evidence of testosterone replacement therapy for the andropause. Maturitas. 2003;45:15-27.
82.
TaylorFLevineL. Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost. J Sex Med. 2010;7(pt 1):269-276.
83.
ToogoodAA. Growth hormone (GH) status and body composition in normal ageing and in elderly adults with GH deficiency. Horm Res. 2003;60(suppl 1):105-111.
84.
TraczMJSiderasKBolonaER. Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials. J Clin Endocrinol Metab. 2006;91:2011-2016.
85.
ValenzanoDRTerzibasiEGenadeTCattaneoADomeniciLCellerinoA. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol. 2006;16:296-300.
86.
VivekananthanDPPennMSSappSKHsuATopolEJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003;361:2017-2023.
87.
WadsworthTLBishopJAPappuASWoltjerRLQuinnJF. Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer’s disease. J Alzheimers Dis. 2008;14:225-234.
88.
WaldMMeachamRBRossLSNiederbergerCS. Testosterone replacement therapy for older men. J Androl. 2006;27:126-132.
89.
WatanabeTKobaSKawamuraM. Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia. Metabolism. 2004;53:476-482.
90.
WilliamsMH. The use of nutritional ergogenic aids in sports: is it an ethical issue?Int J Sport Nutr. 1994;4:120-131.
91.
WoodJGRoginaBLavuS. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 2004;430:686-689.
